Expanding the Euro-BioImaging portfolio


Published April 22, 2020

To remain at the technological forefront, Euro-BioImaging uses “showcasing” and “proof-of-concept” studies to ensure that new technologies are continuously integrated into its portfolio. The first proof-of-concept studies includes Photoacoustic Imaging, Mass Spectrometry Imaging, Coherent anti-Stokes Raman scattering (CARS) microscopy and Quantitative Phase Imaging. These technologies will be offered through the Euro-BioImaging Web Portal for user access once the COVID-19 emergency is under control and Nodes are fully operational. 

Additional technologies that were successfully showcased include: Magnetoencephalography, Correlated Optical Coherence Tomography/Photoacoustic Imaging, Micro X-ray Fluorescence Spectrometry, and Brillouin Light Scattering Microscopy. In the future, new Nodes offering these technologies will be eligible to offer access via the proof-of-concept procedure. In the meantime, Euro-BioImaging welcomes any user, service provider or manufacturer to showcase new technologies for consideration of inclusion into the EuBI portfolio. For more information visit the new technologies page on our Portal:  https://www.eurobioimaging.eu/about-us/new-technologies 


More news from Euro-BioImaging

Euro-BioImaging Map 2025

May 30, 2025

Euro-BioImaging expands!

The Node upgrade process is a process by which existing Euro-BioImaging Nodes can add additional facilities to their Node, expanding the infrastructure by onboarding…

12th Euro-BioImaging Board Meeting

May 27, 2025

Euro-BioImaging Board Meeting in Amsterdam

The 12th Euro-BioImaging Board meeting took place in Amsterdam, from May 13-14, 2025, hosted by our colleagues from NL-BioImaging. It was the occasion for…

May 23, 2025

Imaging for understanding plant disease dynamics

Xylella fastidiosa is a vector-borne gram-negative xylem-limited bacterium native to the Americas, affecting more than 650 plant species, including crops of major economic importance. The bacterial sequence…